
|Articles|April 7, 2017
Stroke Patients Benefit from Using AI
Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform.
Advertisement
Trial results demonstrated that stroke survivors were more likely to take an anti-blood clot treatment when using an artificial intelligence (AI) platform than patients who received treatment normally. The AI platform used software algorithms on smartphones to confirm patient identity, medication and medication ingestion.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
2
What Clinical Trials Can Learn from the Gig Economy About Payments
3
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
4
AI-Driven Clinical Trial Recruitment and Design
5




